Install
Drug Discovery & Trials
Targets, biomarkers, AI discovery, and Phases I–III clinical results.
- 19 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Drug Discovery & Trials
Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
2+ hour, 7+ min ago (204+ words) Goal is to help pharmaceutical innovators evaluate opportunities earlier and accelerate future central nervous system pipelines AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has signed…...
Ingredient Advancements Help Formulators Hone R&D Perspectives
1+ hour, 59+ min ago (164+ words) The number of different ingredients produced via precision fermentation also continues to grow. In addition to the protein analogues for dairy, meat, seafood, and eggs, exhibitors—many located in the Startup Pavilion—also discussed capabilities for producing: Precision fermentation also…...
An Integrated Analytical Approach To Lipase Risk Management In Biologics Development
2+ hour, 27+ min ago (224+ words) Bioprocess Online An Integrated Analytical Approach To Lipase Risk Management In Biologics Development By Kyeyeon Hur, Head of CMC Support; Jimin Kim, Director of Analytical Development; Minjeong Lee, Senior Scientist in Analytical Platform Development; Soojeong Oh | Senior Scientist in Structure…...
SDAIA Showcases Data and AI Initiatives at Fourth Riyadh Global Medical Biotechnology Summit
5+ hour, 18+ min ago (189+ words) Riyadh, September 15, 2026, SPA -- The Saudi Data and AI Authority (SDAIA) is showcasing its key national efforts and initiatives in data and artificial intelligence (AI) at its pavilion during the fourth Riyadh Global Medical Biotechnology Summit 2026 (RGMBS). The summit is being…...
Microsoft: How pharmaceutical leaders are operationalizing AI
7+ hour, 56+ min ago (83+ words) Published on 09/14/2026 at 03:11 pm EDT Microsoft Corporation published this content on September 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 14, 2026 at 19:10 UTC. Can Independent Testing Make AI Safer? September…...
UA Little Rock Researcher Receives Grant to Develop More Realistic Model of Human Intestine
7+ hour, 2+ min ago (788+ words) Recreating the intricate structure of the human intestine in a laboratory could give scientists a better way to study disease and potential treatments — while reducing their reliance on animal experiments in the process. With support from a $72,419 grant, University of…...
Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery - AOL
6+ hour, 7+ min ago (184+ words) AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has signed an agreement for a research collaboration led by Alice Stanton, PhD from Massachusetts General Hospital (MGH)…...
Report: The Insider's Guide to Thought Leadership in Biopharma
5+ hour, 34+ min ago (175+ words) Report: The Insider’s Guide to Thought Leadership in Biopharma BioSpace This guide explores the evolving role of podcasts, webinars, and thought leadership programs in biopharma and provides practical recommendations for public relations agencies, corporate communications teams, and commercial marketers looking…...
How to Do Better Research: A Practical Guide for Medical and Community Medicine Researchers
14+ hour, 54+ min ago (1192+ words) From a Good Research Question to Meaningful Evidence By Dr. Shamin Eabenson, MBBS, MD Community …...
The eastward shift in the biotech world: Why India and China could lead the next wave
1+ day, 2+ hour ago (747+ words) China’s advantage is scale across discovery and development, and India in cost-efficiency and innovation footprint. For decades, the global biotechnology map was largely defined by a handful of established centres in the United States, and Europe. Boston, the Bay Area,…...